OR WAIT null SECS
Will support pharma manufacturers with digital health and commercialization services
Eversana, a provider of global commercial services to the life sciences industry, and S3 Connected Health, a partner in digital health solutions for pharma, have struck a strategic partnership to offer digital health and commercialization services for biopharma manufacturers.
As a unit, both parties will aim to provide various offerings relevant to digital health and patient support. One will be impacting brand planning through personalized support based on real-world insights. Another will focus on improving outcomes and meeting the demands of value-based care via patient services such as human-based support and condition management.
“Digital health solutions are now vital for delivering better, more sustainable healthcare for patients and clinicians into the future," says Jim O’Donoghue, president of S3 Connected Health. “Through this collaboration with Eversana, we will be able to offer complete end-to-end solutions and services for digital health, from co-creation through to commercialization, providing a unique service to our combined customer base.”